Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss is different from male pattern hair loss and has unclear genetic causes.

Male pattern baldness is largely genetic, linked to the androgen receptor gene, and may relate to certain health issues.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

A rare genetic disorder causes sparse hair and vision loss due to a CDH3 gene mutation.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

PRDX5 enzyme may contribute to alopecia areata by affecting oxidative stress and autoimmunity.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Thrombophilic conditions may worsen Long COVID symptoms due to increased blood clotting.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Genetic differences affect how people respond to COVID-19.

Nociplastic pain is a complex, heritable trait with genetic links to chronic and neuropathic pain.

MicroRNAs could help assess and manage multiple chronic diseases.

Premature aging increases the risk of immune problems and autoimmune diseases.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

SOD1 and KL are promising targets for new hair loss treatments.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

ESR2 gene variations may be linked to female pattern hair loss.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Certain gene variations may increase the risk of PCOS in South Indian women.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Aromatase gene variation may increase female hair loss risk.